News, Analysis & Insights on Nutrition, Supplements, and Health
The US Patent and Trademark Office (USPTO) has granted Aker BioMarine's request to re-examine a krill oil patent just awarded to arch rival Neptune Technologies & Bioressources.
The Food and Drug Administration (FDA) has weighed into the debate over the stimulant DMAA (1,3-Dimethylamylamine, also known as methylhexaneamine or MHA), which has garnered more bad press in recent weeks.
John Gay has left the Natural Products Association (NPA) after two years at the helm as executive director and chief executive.
Those hoping the Food and Drug Administration (FDA) is preparing for a major climb down on its draft guidance on new dietary ingredients (NDIs) will draw little comfort from comments made by the agency's supplements chief yesterday.
Reducing levels of the amino acid homocysteine through vitamin therapy still has a role to play in reducing stroke, argue researchers.
NattoPharma has been awarded a Canadian patent covering the use of menaquinone (vitamin K2) in foods and supplements for maintaining, optimizing, strengthening or promoting cardiovascular health.